| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1800012 | 注射用重组全人源抗肿瘤坏死因子受体超家族成员4（OX40）单克隆抗体 | Lyophilized | Biological Products(1) | New Drug Application | 2018-02-09 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2018-07-06 | view |